New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure

Kidney International, Supplement

Volumn 64, Issue 87, 2003, Pages

  Goodman, William G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

End stage renal disease; Parathroid hormone; Renal osteodystrophy

Indexed keywords

CALCITRIOL; CALCIUM; PARATHYROID HORMONE[1-34]; VITAMIN D; PARATHYROID HORMONE;

ANALYTIC METHOD; BONE METABOLISM; BONE TURNOVER; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HISTOLOGY; HUMAN; KIDNEY FAILURE; MINERAL METABOLISM; PARATHYROID HORMONE BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; REVIEW; SECONDARY HYPERPARATHYROIDISM; BLOOD; IMMUNOASSAY; RENAL OSTEODYSTROPHY;

HUMANS; IMMUNOASSAY; KIDNEY FAILURE; PARATHYROID HORMONE; RENAL OSTEODYSTROPHY;

EID: 0142200416     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.64.s87.18.x     Document Type: Review

References (33)

1. NUSSBAUM SR, ZAHRADNIK RJ, LAVIGNE JR, et al: Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364-1367, 1987
2. SHERRARD DJ, HERCZ G, PEI Y, et al: The spectrum of bone disease in end-stage renal failure - An evolving disorder. Kidney Int 43:436-442, 1993
3. SALUSKY IB, RAMIREZ JA, OPPENHEIM WL, et al: Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45:253-258, 1994
4. QUARLES LD, LOBAUGH B, MURPHY G: Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145-150, 1992
5. COHEN-SOLAL ME, SEBERT JL, BOUDAILLIEZ B, et al: Comparison of intact, midregion, and carboxy-terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 73:516-524, 1991
6. TORRES A, LORENZO V, HERNANDEZ D, et al: Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 47:1434-1442, 1995
7. 3, and radiology in end-stage renal disease. Kidney Int 44:1071-1077, 1993
8. GOODMAN WG, RAMIREZ JA, BELIN TR, et al: Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166, 1994
9. SALUSKY IB, FOLEY J, NELSON P, GOODMAN WG: Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. N Engl J Med 324:527-531, 1991
10. Qi Q, MONIER-FAUGERE MC, GENG Z, MALLUCHE HH: Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 26:622-631, 1995
11. MONIER-FAUGERE MC, GENG Z, MAWAD H, et al: Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 60:1460-1468, 2001
12. JOHN MR, GOODMAN WG, GAO P, et al: A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure. J Clin Endocrinol Metab 84:4287-4290, 1999
13. BERSON SA, YALOW RS, AURBACH G, POTTS JT, JR: Immunassay of bovine and human parathyroid hormone. Proc Natl Acad Sci USA 49:613-617, 1963
14. BERSON SA, YALOW RS: Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocrinol Metab 28:1037-1047, 1968
15. SEGRE GV, D'AMOUR P, HULTMAN A, POTTS JT, JR: Effects of hepatectomy, nephrectomy, and nephrectomy/uremia on the metabolism of parathyroid hormone in the rat. J Clin Invest 67:439-448, 1981
16. HABENER JF, KEMPER B, POTTS JT, JR: Calcium-dependent intracellular degradation of parathyroid hormone: A possible mechanism for the regulation of hormone stores. Endocrinology 97:431-441, 1975
17. SEGRE GV, D'AMOUR P, POTTS JT: Metabolism of radioiodinated bovine parathyroid hormone in the rat. Endocrinology 99:1645-1652, 1976
18. FREITAG J, MARTIN KJ, HRUSKA KA, et al: Impaired parathyroid hormone metabolism in patients with chronic renal failure. N Engl J Med 298:29-32, 1978
19. ANDRESS DL, ENDRES DB, MALONEY NA, et al: Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. J Clin Endocrinol Metab 63:1163-1169, 1986
20. SALUSKY IB, COBURN JW, BRILL J, et al: Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33:975-982, 1988
21. ADDISON J, HALES C, WOODHEAD J, O'RIORDAN J: Immunoradiometric assay of parathyroid hormone. J Endocrinol 49:521-530, 1971
22. LEPAGE R, ROY L, BROSSARD JH, et al: A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805-809, 1998
23. GAO P, SCHEIBEL S, D'AMOUR P, et al: Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605-614, 2001
24. BROSSARD JH, CLOUTIER M, ROY L, et al: Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values. J Clin Endocrinol Metab 81:3923-3929, 1996
25. BROSSARD JH, LEPAGE R, CARDINAL H, et al: Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem 46:697-703, 2000
26. SLATOPOLSKY E, FINCH J, CLAY P, et al: A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753-761, 2000
27. ANDRESS DL, NORRIS KC, COBURN JW, et al: Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274-279, 1989
28. SALUSKY IB, KUIZON BD, BELIN T, et al: Intermittent calcitriol therapy in secondary hyperparathyroidism. A comparison between oral and intraperitoneal administration. Kidney Int 54:907-914, 1998
29. SALUSKY IB, GOODMAN WG: Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy. Kidney Int 48:657-665, 1995
30. COEN G, BONUCCI E, BALLANTI P, et al: PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 40:348-354, 2002
31. SALUSKY IB, GOODMAN WG, KUIZON BD, et al: Similar predictive value of bone turnover using first and second generation immunometric PTH assays in dialyzed children. Kidney Int 63:1801-1808, 2003
32. DIVIETI P, JOHN MR, JÜPPNER H, BRINGHURST FR: Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology 143:171-176, 2002
33. DIVIETI P, INOMATA N, CHAPIN K, et al: Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells. Endocrinology 142:916-925, 2001